Pre-Surgical Immunotherapy Identifies Potential Benefit, Risk of Recurrence in Melanoma – Curetoday.com
Pre-Surgical Immunotherapy Identifies Potential Benefit, Risk of Recurrence in MelanomaCuretoday.comFor patients with melanoma, administration of a PD-1 checkpoint blockade therapy in the neoadjuvant setting – meaning it was given before the main treat… Continue reading
